Update beim Hebeltrade auf MorphoSys und Bayer – Chancen bei Alibaba

Bei Bayer und MorphoSys gibt es News zu Medikamenten – China will die ADR´s weiter unterstützen. Für mehr Details, hört doch mal rein!

Episode metadata supplied by the publisher feed · Published Mar 16, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Update beim Hebeltrade auf MorphoSys und Bayer – Chancen bei Alibaba

0:00 7:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on March 16, 2022.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!